Thomas Gardner

Thomas Gardner has over 18 years of diverse work experience in various scientific and research roles. Thomas is currently working as a Senior Scientist II at ArsenalBio since August 2020. Prior to that, they served as a Postdoctoral Fellow at the Memorial Sloan Kettering Cancer Center from July 2016 to August 2020. Thomas also co-founded NovoCount and served as the Vice President of Technology from September 2013 to July 2016.

Before NovoCount, Thomas worked as a PhD Candidate at the Icahn School of Medicine at Mount Sinai from August 2010 to June 2016. Thomas also gained experience as a Professional Research Assistant at the Barbara Davis Center - University of Colorado Denver from November 2008 to July 2010. Additionally, Thomas worked as a North American Language and Culture Assistant at the Consejeria de Educación de la Comunidad de Madrid, where they developed curricula for bilingual science and reading programs at a primary school in Madrid from October 2007 to July 2008.

Early in their career, Thomas worked as a Chemical Formulations Technician at Endo Pharmaceuticals from January 2007 to September 2007. Thomas also gained research experience as an Undergraduate Research Assistant at the University of Colorado at Boulder, working in the lab of Dr. Michael Klymkowsky, where they investigated developmental and molecular mechanisms in Xenopus laevis from September 2002 to December 2006.

Thomas Gardner has a Bachelor of Arts degree in Molecular Cellular Developmental Biology from the University of Colorado Boulder, which they obtained between 2002 and 2006. From 2010 to 2015, they pursued a Doctor of Philosophy (Ph.D.) in Microbiology and Immunology at the Icahn School of Medicine at Mount Sinai. Additionally, Thomas may have had some form of education at the Memorial Sloan Kettering Cancer Center, although specific details such as start and end years, degree name, and field of study are not provided.